TrialHuman vaccines & immunotherapeutics2018

A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adults.

Geert Leroux-Roels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.